Free Choline, but Not Phosphatidylcholine, Elevates Circulating Trimethylamine-N-oxide and This Response Is Modified by the Gut Microbiota Composition in Healthy Men

Clara Cho,Niklas DJ Aardema,Madison L Bunnell,Deanna P Larson,Sheryl S Aguilar,Janet R Bergeson,Olga V Malysheva,Marie A Caudill,Michael Lefevre,Niklas D J Aardema
DOI: https://doi.org/10.1093/cdn/nzaa045_012
2020-05-29
Current Developments in Nutrition
Abstract:Abstract Objectives Trimethylamine-N-oxide (TMAO), a choline-derived gut microbiota-dependent metabolite, is a newly recognized risk marker for cardiovascular disease. However, the contributions of different forms of choline and gut microbiota composition on TMAO production are largely unknown. The objectives of this study were to: 1) compare acute TMAO response to meals containing free choline (choline bitartrate) versus fat-soluble choline (phosphatidylcholine) and 2) to determine the effects of gut microbiota composition on TMAO response. Methods In a controlled, double-blinded, cross-over study, healthy men (n = 37) were provided meals containing (i) 600 mg choline as choline bitartrate (free choline); (ii) 600 mg choline as phosphatidylcholine; or (iii) no choline control in a random order. Blood and urine samples were collected at baseline and throughout the 6-h study period; a one-time stool sample was collected at baseline. Results Compared to no choline and phosphatidylcholine, free choline yielded 295% higher plasma TMAO (P = 0.002) and 250% higher urinary TMAO (P = 0.01), with no difference in TMAO response between phosphatidylcholine and no choline. High-TMAO producers (those with ≥40% increase in urinary TMAO response to free choline) had significantly different beta-diversity measures (unweighted UniFrac; PERMANOVA P = 0.01) compared to low-TMAO producers (those with <40% increase in TMAO response) but showed no difference in alpha-diversity. Analysis of Composition of Microbiomes (ANCOM) revealed that high-TMAO producers had more abundant lineages of Clostridium from Ruminococcaceae and Lachnospiraceae (in phylum Firmicutes) compared to low-TMAO producers (P < 0.05 with the strength of the ANCOM test W = 11 and W = 8, respectively). Conclusions Given that the majority of choline in food is in the form of phosphatidylcholine, the absence of TMAO elevation with phosphatidylcholine counters arguments that dietary choline should be avoided for TMAO-producing characteristics. Further, development of individualized dietary recommendations based on the gut microbiota composition may be a more appropriate strategy to reduce risk of cardiovascular disease. Funding Sources This research was supported by the Utah Agricultural Experiment Station Seed Grants Program.
What problem does this paper attempt to address?
This paper aims to explore the effects of different forms of choline (such as free choline and phosphatidylcholine) on the levels of trimethylamine - N - oxide (TMAO) in healthy men, and how the gut microbiome composition affects this response. Specifically, the research objectives are: 1. To compare the acute responses of TMAO levels to meals containing free choline (choline tartrate) and fat - soluble choline (phosphatidylcholine). 2. To determine the influence of gut microbiome composition on the TMAO response. Through this study, the authors hope to understand whether different forms of choline will lead to different amounts of TMAO production, and to explore whether these differences are related to the gut microbiome composition of individuals. This helps to assess whether choline intake in the diet should be avoided due to the production characteristics of TMAO, and whether personalized diet recommendations based on an individual's gut microbiome composition can be more effective in reducing the risk of cardiovascular diseases.